Related Experiment Videos
Oral amyloidosis: a late complication of multiple myeloma
Abstract:
Amyloidosis as a complication of multiple myeloma carries with it grave prognostic implications, and the median survival of myeloma patients following a diagnosis of amyloidosis is only 4 months. This article describes a patient who survived 6 years with kappa light chain myeloma, but only 4 months after the development of oral amyloid deposits. Oral amyloidosis may be clinically difficult to distinguish from fibrous, neurogenous, or salivary gland pathosis; however, histologic specimens stained with Congo red have a characteristic "apple green" appearance when examined microscopically with polarized light.
Insights
Amyloidosis, a serious multiple myeloma complication, significantly worsens prognosis. This case highlights a patient surviving only 4 months after developing oral amyloid deposits, underscoring the disease
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Multiple myeloma is a plasma cell malignancy.
- Amyloidosis is a known complication of multiple myeloma.
- Amyloidosis significantly impacts patient prognosis.
Observation:
- A patient with kappa light chain myeloma survived for 6 years.
- The patient developed oral amyloid deposits.
- Oral amyloidosis presented challenges in clinical diagnosis.
Findings:
- The median survival for myeloma patients with amyloidosis is approximately 4 months.
- This patient survived only 4 months after the onset of oral amyloidosis.
- Histologic examination of oral amyloid deposits with Congo red staining reveals characteristic "apple green" birefringence under polarized light.
Implications:
- Oral amyloidosis diagnosis requires histologic confirmation.
- Early detection and management of amyloidosis in multiple myeloma patients are crucial.
- Understanding the prognostic impact of amyloidosis is vital for patient care.